Department of Cardiothoracic Surgery, John Hunter Hospital, Newcastle, Australia.
The Collaborative Research Group (CORE), Sydney, Australia.
J Cardiothorac Surg. 2021 Dec 7;16(1):349. doi: 10.1186/s13019-021-01727-0.
Infective endocarditis is a disease that carries high morbidity and mortality. The primary endpoint of this study is to assess factors associated with in-hospital mortality in patients undergoing valvular surgery for infective endocarditis. The secondary endpoint of this study is to assess the incidence of post-operative stroke, renal failure, complete heart block and recurrence.
Between the years of 2015 to 2019, a total of 89 patients underwent surgery for infective endocarditis at Fiona Stanley Hospital, Western Australia. Data was collected from the Australia and New Zealand Cardiac Surgery Database from 2015 to 2019 as well as patients electronic medical record. A number of preoperative and perioperative factors were assessed in relation to patient mortality and morbidity. Univariate and multivariate logistical regression analysis was done to assess for the association between factors and in-hospital morbidity and mortality.
A total of 89 patients underwent surgery for infective endocarditis from 2015 to 2019, affecting a total of 101 valves. The mean age of patients was 53.7 ± 16.5. A total of 79 patients had a positive blood culture pre-operatively, with Staphylococcus Aureus being the most frequently cultured organism (39%). Fourteen patients (16%) were deemed emergent and underwent surgery within 24 h of review. A total of five patients died within their hospital stay postoperatively. Variables significantly associated with mortality on univariate analysis were intravenous drug use, emergent surgery, perioperative dialysis, perioperative inotropes, cardiopulmonary bypass time and cross clamp time. Only CBP time was significantly associated with mortality on multivariate analysis. A total of 19 patients (21%) required hemodialysis after surgery, 10 patients sustained a postoperative stroke (11%), 11 patients developed a complete heart block post operatively (12%) and endocarditis recurred in 10 patients (11%).
Prolonged cardiopulmonary bypass times were significantly associated with mortality. This study is novel to report a lower mortality rate than previously quoted in the literature. We also report our findings of organisms, preoperative embolic phenomena and surgery in a Western Australian population. We recommend that all patients with endocarditis are discussed in multidisciplinary forum.
感染性心内膜炎是一种发病率和死亡率都很高的疾病。本研究的主要终点是评估接受瓣膜手术治疗感染性心内膜炎患者住院期间死亡的相关因素。本研究的次要终点是评估术后中风、肾衰竭、完全性心脏阻滞和复发的发生率。
在 2015 年至 2019 年期间,共有 89 名患者在西澳大利亚的菲奥娜·斯坦利医院接受了感染性心内膜炎手术。数据来自 2015 年至 2019 年的澳大利亚和新西兰心脏外科学数据库以及患者的电子病历。评估了与患者死亡率和发病率相关的术前和围手术期多种因素。采用单变量和多变量逻辑回归分析评估因素与住院期间发病率和死亡率的相关性。
2015 年至 2019 年期间,共有 89 名患者因感染性心内膜炎接受手术,共涉及 101 个瓣膜。患者的平均年龄为 53.7±16.5 岁。共有 79 名患者术前血培养阳性,最常培养的病原体是金黄色葡萄球菌(39%)。14 名患者(16%)为急诊,在就诊后 24 小时内接受手术。共有 5 名患者术后住院期间死亡。单变量分析中与死亡率显著相关的变量是静脉吸毒、急诊手术、围手术期透析、围手术期正性肌力药、体外循环时间和主动脉阻断时间。只有体外循环时间在多变量分析中与死亡率显著相关。共有 19 名患者(21%)术后需要血液透析,10 名患者发生术后中风(11%),11 名患者术后发生完全性心脏阻滞(12%),10 名患者(11%)心内膜炎复发。
体外循环时间延长与死亡率显著相关。本研究报告的死亡率低于文献中的先前报道,具有创新性。我们还报告了我们在西澳大利亚人群中发现的病原体、术前栓塞现象和手术情况。我们建议所有心内膜炎患者都在多学科论坛中进行讨论。